by John R. Fischer
, Senior Reporter | April 28, 2023
Irish radiology equipment distributor and servicer Medray Imaging Systems Group has acquired Hulbert Imaging in the U.K., expanding its portfolio of X-ray imaging equipment for purchase by radiology departments and private sector specialists.
Irish trade publication Business Plus broke the news on April 26
Founded in 1979, Medray is an exclusive distributor of X-ray equipment and accessories for Carestream in the U.K. and supplies radiology, dental and associated market products to providers within Britain’s National Health Service, Ireland’s Health Service Executive system, NHS Northern Ireland, nursing homes, veterinary practices, dental surgeries, and chiropractic clinics.
It employs over 100 individuals in Ireland and the U.K., and its products include X-ray, CT, fluoroscopy and ultrasound solutions from Carestream, Epson, Fujifilm, GMM, Planmeca and Vidar; accessories from IMS, Kenex, ProtecX, Parker and Raybloc; dosimetry solutions from Mirion Technologies; and consumables like personal protective equipment.
As of 2021, Medray’s annual revenue stands at €24.3 million (over $26 million), up 24.5% from 2020, with a profit before tax of €2.5 million (over $2.7 million), reported Business Plus.
Based in Worcester, England, Hulbert was founded in 2003, and provides head and neck imaging solutions and dental equipment to NHS radiology departments, dentists, and private healthcare facilities.
It manages over £3 million (over $3.7 million) worth of integrated imaging assets on full service contracts, including Carestream head and neck imaging solutions, PACS and RIS systems, and dentistry technologies. It also provides call-out engineering services and remote assistance.
The acquisition of Hulbert is Medray’s third deal since 2019 when it was acquired by private equity group Erisberg, which has invested €110 million (over $120 million) in Irish businesses, including in healthcare, according to Business Plus.
Financial details of the Hulbert acquisition were not disclosed.
Medray did not respond to HCB News for comment.